C. Teitel

发表

Personalizing nutrigenomics research through community based participatory research and omics technologies.

Margaret L Bogle, Jim Kaput, Baitang Ning, 2008, Omics : a journal of integrative biology.

Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.

M. Butler, G. Talaska, F. Kadlubar, 1990, Progress in clinical and biological research.

Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.

M. Butler, S. Tannenbaum, J. F. Young, 1991, Cancer research.

Metabolic activation of aromatic amines by human pancreas.

J. Potter, K. Anderson, R. Minchin, 1997, Carcinogenesis.

N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.

R. Minchin, F. Kadlubar, K. Ilett, 1992, Biochemical and biophysical research communications.

Expression of monomorphic and polymorphic N-acetyltransferases in human colon.

R. Minchin, D. Carpenter, F. Kadlubar, 1994, Biochemical pharmacology.

Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues.

R. Minchin, G. Mulder, F. Kadlubar, 1994, Carcinogenesis.

Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes.

J. Shaddock, D. Casciano, G. Mulder, 1994, Carcinogenesis.

Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.

S. J. Culp, G. Talaska, J. Lay, 1997, Mutation research.

Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat.

F. Kadlubar, W. Huber, L. P. McDaniel, 1997, Mutation research.

Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study

Melissa J. Morine, B. Ning, C. Priami, 2014, Genes & Nutrition.

Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation.

P. Thompson, F. Kadlubar, D. Lin, 2003, Mutation research.

Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.

G. Mulder, F. Kadlubar, R. Turesky, 1994, Carcinogenesis.

Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.

H. Bartsch, M. Butler, R. Minchin, 1995, Princess Takamatsu symposia.

Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.

J. Lay, F. Kadlubar, D. Roberts, 2004, Chemical research in toxicology.

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

R. Hayes, P. Vineis, M. Butler, 1992, Pharmacogenetics.

In vitro bioactivation of N-hydroxy-2-amino-α-carboline

F. Kadlubar, Fred F. Kadlubar, C. Teitel, 2000 .

In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline.

F. Kadlubar, C. Teitel, R. King, 2000, Carcinogenesis.

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression.

B. Green, C. Rauch, F. Morel, 2001, Pharmacogenetics.

Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

M. Butler, F. Kadlubar, R. Turesky, 1991, Carcinogenesis.

Genetic associations with micronutrient levels identified in immune and gastrointestinal networks

Melissa J. Morine, B. Ning, C. Priami, 2014, Genes & Nutrition.

Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry.

F. Kadlubar, P. Vouros, C. Teitel, 2005, Chemical research in toxicology.

Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines.

F. Guengerich, F. Kadlubar, Donghak Kim, 2004, Chemical research in toxicology.

Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N‐acetyltransferase and glutathione S‐transferase activities

J. Shaddock, D. Casciano, G. Mulder, 2004, Environmental and molecular mutagenesis.

Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative.

J. Shaddock, D. Casciano, F. Kadlubar, 1999, Cancer letters.

Cystine-Glutamate Transporter SLC7A11 Mediates Resistance to Geldanamycin but Not to 17-(Allylamino)-17-demethoxygeldanamycin

Paul E. Blower, Ying Huang, Baitang Ning, 2007, Molecular Pharmacology.

Methylation potential associated with diet, genotype, protein, and metabolite levels in the Delta Obesity Vitamin Study

Melissa J. Morine, B. Ning, C. Priami, 2014, Genes & Nutrition.

Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS)

Weida Tong, Huixiao Hong, Leming Shi, 2005, BMC Bioinformatics.

Expression of cytochromes P450 and glutathione S‐transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl‐coA‐, PAPS‐ and ATP‐dependent pathways

F. Kadlubar, B. Coles, C. Teitel, 2005, International journal of cancer.